Estee Lauder continues to struggle while those with less China exposure such as Kose look more attractive. Uncertainty over 7&I deal should lift NKY225 replacements like PPIH.
What is covered in the Full Insight:
Estee Lauder's China Strategy
Short-term Market Impact of 7&I Deal
Tech Sector Performance and Acquisitions
Implications of NKY225 Rebalancing
PPIH's Market Position and Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.